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Abstract Transorallasermicrosurgery(TLM)isanemerging
techniqueforthemanagementoflaryngealandotherheadand
neck malignancies. It is increasingly being used in place of
traditional open surgery because of lower morbidity and
improved organ preservation. Since the surgery is performed
from the inside working outward as opposed to working from
the outside in,thereislessdamagetothesupportingstructures
that lie external to the tumor. Coupling the laser to a
micromanipulator and a microscope allows precise tissue
cutting and hemostasis; thereby improving visualization and
precise ablation. The basic approach and principles of
performing TLM, the devices currently in use, and the
associated dosimetry parameters will be discussed. The
benefits of using TLM over conventional surgery, common
complicationsandthedifferentsettingsuseddependingonthe
locationofthetumorwillalsobediscussed.AlthoughtheCO2
laser is the most versatile and the best-suited laser for TLM
applications, a variety of lasers and different parameters are
used in the treatment of laryngeal cancer. Improved
instrumentation has lead to an increased utilization of TLM
by head and neck cancer surgeons and has resulted in
improved outcomes. Laser energy levels and spot size are





Over the last 50 years, advances in the management of
laryngeal cancer have resulted in treatments with increased
effectiveness as well as improved function. With the
development of new conservation surgical techniques,
advances in delivery of radiation treatments, and develop-
ment of organ preservation regimens using chemotherapy
(CT) combined with radiotherapy (RT), decision-making
has become more complex.
Over the last 20 years, organ preservation surgery has
evolved from standard external surgical approaches to
resect cancer and preserve parts of the larynx to surgical
procedures resecting equivalent tumors performed through
an endoscope. These operations turn the operative paradigm
“inside out”. They require re-learning the surgical anatomy
from a new perspective, and development of skills to resect
tumors through the lumen of long, narrow endoscopes. This
has required critical examination and validation of onco-
logical effectiveness of surgical resection, and surgeons
learning a new skill set to successfully perform these
procedures.
This review outlines the development of transoral laser
microsurgery (TLM), provides rationale for treatment
selection, describes a practical description of surgical
technique, and analyzes technical factors associated with
the use of the carbon dioxide laser in surgical management
of laryngeal cancer.
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American Society for Laser Medicine and Surgery. April 1–5, 2009,
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Laryngeal cancer is the second most common cancer in
the upper aerodigestive tract, with over 12,000 new cases
a year in the United States and nearly 3,000 annual
deaths [1]. Approximately 95% of laryngeal cancers are
squamous cell carcinomas (SCC), and a significant
majority occur in patients between 60 and 70 years old
[2]. The overall 5-year survival rate for laryngeal SCC is
64% [3]. The risk of developing laryngeal SCC has been
closely related to tobacco and alcohol use, and is
proportional to the amount and duration of use. Further-
more, tobacco and alcohol act synergistically [4–8]. Other
potential risk factors for laryngeal SCC include laryngo-
pharyngeal reflux [9, 10], as well as occupational
exposure to asbestos and other environmental toxins.
Because of confounding variables and low prevalence of
most occupational exposures, definitive assessment is
difficult and the contribution of these factors is debated
[11, 12]. In recent years, a relationship between human
papillomavirus (HPV) and head and neck cancer has been
elucidated. Although the association is strongest for
pharyngeal cancers, there appears to be at least a weak
association with development of laryngeal cancer [13–15].
Genetic predisposition is also a contributing factor for the
likelihood of developing HNSCC, partially explaining
why some heavy smokers and drinkers fail to develop
cancer, while some young persons with no significant
exposure to tobacco, alcohol, or HPV exposure develop
aggressive tumors [16].
Anatomy and staging
The larynx is a complex organ with a primary evolutionary
function to protect the lungs from aspiration of food and
water, with phonation and voice production as secondary
adaptations. The larynx is composed of cartilages, connec-
tive tissue barriers, muscles, and soft tissues that act in a
coordinated fashion to allow sphincteric control of the
airway. The larynx is divided anatomically into the supra-
glottic, glottic, and subglottic regions, and is illustrated in
Fig. 1. A full description of laryngeal anatomy is beyond
the scope of this article, and the reader is directed to the
references sited below [17–19].
Head and neck cancer is also a heterogeneous disease,
with different behavior and prognosis at each region of the
head and neck, and within the larynx between the three
subsites. Prognosis and treatment selection is dependent in
large part on tumor staging using the TNM staging system
of the American Joint Committee on Cancer (AJCC).
Staging is based on the anatomical location of the tumor,
tumor spread to the cervical lymph nodes, and distant
metastasis. Using the TNM stage, patients are divided into
four stage groups (I–IV), which provides a good stratifica-
tion of survival probability and aids selection of appropriate
treatment modalities. A full description of the staging
system is provided in the AJCC staging manual [20].
Early stage cancer (stages I and II) is generally managed
with single modality therapy, and treatment selection is
based primarily on treatment morbidity as surgery and RT
generally have similar cure rates. For advanced stage
(stages III and IV) disease, combined modality therapies
are generally used, and decisions regarding the ability to
preserve the larynx are critical.
Endoscopic approaches to manage laryngeal cancer have
developed over the last 30 years, and with increased
anatomic understanding, clinical experience, and long-
term results demonstrating oncological efficacy, transoral
laser microsurgery (TLM) on the larynx has become an
accepted treatment modality for both early laryngeal cancer,
and as an organ preservation technique for advanced
laryngeal cancers.
Overview of treatment options for laryngeal cancer
Surgical treatment
Total laryngectomy is performed for advanced laryngeal
cancer, and is the gold standard oncologically. It is also
debilitating, relegating recipients of this procedure to
breathing through an artificial stoma in the neck, and
learning alternative methods to speak without a voice box.
Dissatisfaction with the morbidity of the total laryngectomy
led to progressive development of conservation surgical
procedures to remove portions of the larynx. For glottic
tumors, removal of the vocal cord (cordectomy) and external
vertical partial laryngectomy were developed to treat early
glottic cancers. For supraglottic cancer, the supraglottic
laryngectomy, which removes the epiglottis, preepiglottic
space, and false vocal cords, was developed to preserve
speechfunctionandavoidapermanentstomaortracheostomy
[21, 22]. When contemplating conservation surgery, it is
important to consider several basic concepts when evaluating
if a patient is eligible for a conservation laryngectomy. It is
critical to be able to accurately assess the complete tumor
extent, and determine if the tumor can be resected with
adequate oncologic margins and preserve the critical
structures necessary for maintenance of laryngeal function
to preserve the airway and maintain adequate phonatory
function. The cricoarytenoid unit forms the basic functional
unit of the larynx. Fundamentally, adequate laryngeal
function requires preservation of at least, one functional
cricoarytenoid joint, and the cricoid cartilage for the patient
to be a candidate for conservation laryngectomy. [23].
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my) is oncologically effective when performed on appropri-
ately selected patients by competent surgeons. A limitation of
open procedures is that intervening normal structures are
either transected or resected to access the intraluminal tumor
from an external approach. Open surgical approaches disrupt
the strap muscles, laryngeal cartilages, nerves, and blood
supply to tissues external to the tumor. This results in
postoperative swelling necessitating temporary tracheostomy,
impairment of laryngeal elevation, and loss of sensation,
resulting in swallowing dysfunction and aspiration in the
postoperativeperiod.Chronicaspirationisthenormwithopen
supraglottic laryngectomies. This limited the number of
patients who were eligible for these procedures to those with
good pulmonary function who could withstand several
months of chronic aspiration while they heal and re-learn
how to swallow. Open resection of glottic tumors results in
postoperative airway swelling necessitating tracheostomy,
either from the resection, or the soft tissue reconstructions
designed to restore soft tissue removed during resection of the
tumor. Because of the soft tissue disruption, airway stenosis
from scarring and/or extensive atrophy resulting in aphonia
are common and often lead to unpredictable functional
outcomes. These limitations of traditional open conservation
approaches led to efforts to develop endoscopic techniques to
treat laryngeal cancers, described below.
Radiation therapy
Radiation therapy is an effective treatment for early
laryngeal cancers. Treatment is performed daily over a
5–7 week period. It has the advantage of being a
nonsurgical modality, and voice outcome for glottic
cancer is generally very good. There are several
limitations to primary RT. The primary limitation is RT
generally cannot be repeated for curative purposes if
there is recurrence, or a second primary in the previously
radiated field [24]. RT is often used with other treatment
modalities. Postoperative RT is used in locally advanced
laryngeal tumors to decrease recurrence [25]. It is also
used with CT in a variety of organ preservation regimens
described below [26].
Photodynamic therapy (PDT) is a treatment modality
that has demonstrated effectiveness, especially for superfi-
cial head and neck cancers. A light-activated pro-drug is
administered, and it accumulates preferentially in cancer
cells. The drug is activated by light of a specific wavelength
catalyzing reactions that result in release of oxygen free
radicals that are cytotoxic to the cells accumulating the
drug. PDT produces a variable length of photosensitivity
following treatment that is dependent on the agent used.
Although impressive results have been reported [27, 28],
the technique is not yet widely available.
Organ preservation strategies
In 1991, the Department of Veterans Affairs Laryngeal
Cancer Study Group published a landmark randomized
controlled clinical trial comparing an organ preservation
protocol with total laryngectomy. Induction CT followed by
RT in clinical responders in carefully selected laryngeal
cancer patients produced an equivalent cure rate to those
patients receiving TL, while preserving the larynx in
approximately two-thirds of cases [29]. This trial demon-
strated the oncologic viability of organ preservation of the
larynx, and launched a new trend for organ preservation in
selected advanced laryngeal cancers. In 2003, the Radiation
Therapy Oncology Group and the Head and Neck Inter-
group published a trial (RTOG 91-11) that confirmed that
the use of concurrent chemoradiation therapy (CRT)
significantly improved locoregional control and organ
preservation compared to CT followed by adjuvant RT or
RT alone [30], making concurrent CRT a new organ
preservation treatment standard for selected advanced
laryngeal cancers. Subjects receiving radiation alone did
not fare as well as either the concomitant or neoadjuvant
CT groups. This study excluded advanced T4 lesions with
cartilage invasion or extralaryngeal spread [26]. Since the
introduction of organ preservation strategies, the indication
for radical surgery, a total laryngectomy (TL), has declined.
Fig. 1 Diagram of the
larynx showing the different
sites and subsites (adapted
from Coates GM, Schenck HP.
Otolaryngology. W.F. Prior Co.,
Hagerstown, MD. 1966, Vol. 5,
Chapter 7, page 4)
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treatment regimen. Mortality of up to 4% has been reported
in major series [31]. Many patients undergoing these
treatments experience prolonged loss of swallowing func-
tion, and in a minority of patients, long-term fibrosis results
in anatomic preservation of a nonfunctional larynx. TL is
indicated when the disease cannot be treated with partial
laryngectomy, CT or RT, or when the laryngeal tumor has
invaded extralaryngeal tissues of the neck [32].
Transoral laser microsurgery (TLM) for laryngeal
cancer
What is TLM?
Transoral laser microresection, in laryngeal cancer is the
oncologic resection of tumors performed through an
endoscopic as opposed to an external surgical approach.
Tumors are visualized through an endoscope, resected
using lasers or other cutting and coagulation methods, and
the wound bed is left open to heal by secondary intention.
Historical development
The historical evolution of TLM for laryngeal cancer goes
all the way back to the early days of laryngeal surgery.
Chevalier Jackson was perhaps the first to endoscopically
resect a tumor of the epiglottis through an endoscope with
cup forceps in 1915 [33, 34]. Because of very primitive
equipment, the ability to perform transoral resections of
tumors was limited, and tumor resections of the larynx were
only occasionally performed.
As laryngology developed, technological advances laid
the groundwork to allow endoscopic surgical resections.
The first advance was the development of fiber-optic light
sources, to allow distal illumination of the airways. A
second important advance was the development and use of
the operative microscope, which allowed magnified views
of the larynx. In conjunction with magnification was the
development of smaller instruments adapted from otologic
instruments to manipulate tissues within the larynx. The
critical advance that allowed transoral laser microsurgery to
develop was coupling of the newly developed carbon
dioxide laser to the microscope and developing micro-
manipulators to precisely deliver energy to the larynx. In
1972, Strong and Jako [35] coupled a CO2 laser to a
surgical microscope for use through a laryngoscope,
introducing a new modality for the treatment of benign
laryngeal pathologies. Three years later, in 1975, Strong
[36] used the CO2 laser to successfully treat 11 patients
with early T1 laryngeal cancer. In 1978, Vaughan [37] first
reported the use of the CO2 laser to resect supraglottic
tumors. Based on the early work by Strong and Vaughan,
Steiner [38–41] worked to develop new endoscopes to aid
exposure, developed sturdy instruments to grasp and retract
the larynx, worked out techniques to obtain and maintain
hemostasis through the endoscope, and importantly dem-
onstrated that tumors could be resected in sections with
oncologic safety. Importantly, these techniques have been
adapted by others [42–48], and the oncologic effectiveness
has been replicated, treating different stages and locations
of laryngeal cancer.
The indications for TLM parallel those for open
conservation surgery. The tumor must be oncologically
amenable to surgical resection for cure. In addition to the
oncological indications is the ability to visualize the tumor
through the endoscope. Anatomic factors that limit the
ability to expose the larynx include trismus, inability to
extend the neck, a large tongue base, prominent dentition,
and other anatomic factors that prevent the insertion of
endoscopes to expose the tumor (see Table 1). TLM has
several advantages over traditional open surgery, namely a
lower incidence of complications in comparison to open
surgery, such as a decrease in the need for tracheostomy
[46, 49], pharyngocutaneous fistulas [49], and lower
postoperative morbidity [24].
The CO2 laser has an infrared beam with a wavelength of
10.6 μm. It is delivered into the airway along the axis of the
microscope visual field using a micromanipulator coupled to
the microscope. The micromanipulator allows precise control
of beam delivery to precisely cut through tissues and obtain
hemostasis. The carbon dioxide laser has ideal tissue
properties for surgery in the larynx because of its high
coefficient of extinction in water, which limits soft tissue
penetration and minimizes collateral thermal effects, while
providing generally adequate hemostasis. Recently, laser
delivery through a flexible hollow tube has become available
to deliver the laser beam close to the target. The advantage of
the flexible systems is the ability to have limited bending of
the fiber within the endoscope to vary the angle of attack for
cutting through tissues and to allow easier access to some
Table 1 Indications and contraindications for TLM in malignant lesions
INDICATIONS
￿ Tumors amenable to conservation laryngeal surgery T1, T2, and
selected T3 tumors
￿ Ability to adequately expose the larynx
￿ Palliative tumor debulking
CONTRAINDICATIONS
￿ Extensive tumors
○ Extralaryngeal tumor spread
○ Inability to preserve cricoid and one arytenoid
￿ Inadequate endoscopic access
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The primary limitations of these systems are limited
angulation and as with use of standard microlaryngeal
instruments, the effect of natural surgeon tremor is magnified
along the shaft of the instrument [50, 51].
Although the CO2 laser was the first to be used in the
larynx, a number of other lasers have been used within the
larynx. They differ in method of delivery of the energy,
tissue penetration, and tissue cutting and hemostatic
capabilities. The KTP (532 nm) laser has excellent
hemostatic properties with a slight increase in the depth of
tissue injury. It is delivered through a quartz fiber, which
for selected tumors can be advantageous. Recently, pulsed
KTP lasers have become available for tissue photoablation.
For premalignant lesions, and selected early glottic carci-
nomas, experience with 585- and 595-nm pulsed dye lasers
has been reported [48, 52]. Other lasers, including thulium
and gold lasers, have recently become available and are
being evaluated [53–55].
Operative technique
Thorough and accurate preoperative evaluation and staging
are critical for operative success. The lesion must be
accurately visualized either in the office or through operative
endoscopy, and histological confirmation of malignancy is
mandatory.Forlargertumors,imagingwithMRIorCTscanis
performed toevaluatefor bothhiddendeepinvasionoftumor,
and nodal metastases. Once the patient is in the operating
room under general anesthesia, a confirmatory direct laryn-
goscopy is performed. Before starting the laser resection, it is
very important to implement several laser safety measures to
minimizethe riskofcomplications fromthe laser surgery. The
primary risks ofthe laser are burns tothe patient and members
of the operative team. First it is important to protect the
patient’s eyes with protective eye pads wet with saline
(Fig. 2). Likewise, all operative personnel must wear
protective eyeglasses. Signs are placed outside the OR to
indicate that a laser is in use. The facial skin is protected
using surgical towels soaked in saline solution, and these
towels need to be kept wet during the entire procedure. A
smoke evacuator is used to remove laser plume created by
the laser. We use a protected endotracheal tube designed to
decrease the risk of ignition from laser impact (Fig. 3). The
cuff of the laser-protected tube is inflated using saline with
methylene blue dye to help identify endotracheal tube cuff
rupture, and help prevent tube ignition if there is cuff
damage during the procedure. Irrigation solution with bulb
syringes is immediately available in the event of ignition of
the drapes or other flammable materials. The oxygen
concentration is also lowered to below 30% FiO2 when
using the laser to decrease the likelihood of fire [56]. In the
event of an airway fire, the endotracheal tube is immediately
removed, the airway is re-secured, bronchoscopy is per-
formed, and the procedure is terminated.
Once the patient is prepared, the patient is placed in a
supine position with the head fully extended. The dentition
is protected using either a plastic or metal tooth guard, or as
we prefer, a custom thermoplastic splint to cover the teeth.
Using one of a variety of rigid laryngoscopes selected to
visualize the desired structures (Fig. 4), the larynx is
visualized through the laryngoscope (Fig. 5). Once ade-
quate exposure is obtained, the laryngoscope is fixed using
a suspension arm (Fig. 6). Laryngeal suspension frees both
hands for operative manipulation.
The microscope is brought into position and the laser is
coupled to the micromanipulator (Fig. 7). Along with the
invisible CO2 laser beam is a coaxial helium-neon (He-Ne)
laser aiming beam to align the laser to the target. Prior to
surgery, the laser is tested to ensure both proper function
and alignment of the CO2 and He-Ne beams.
The primary advantage of the CO2 laser coupled to a
micromanipulator is that precise tissue cutting and coagu-
lation can be achieved, which reduces the collateral damage
to the surrounding tissues. Because the laser is delivered
from a joystick-controlled micromanipulator, there is
unimpaired visualization of the target, limited motion
artifact from surgeon tremor, and one hand remains free
to retract tissues or suction out debris while operating the
laser (Fig. 8).
Small tumors (e.g., small superficial T1 glottic tumor)
can be resected en bloc by cutting around the tumor and
removing it in one piece. Another option for small tumors,
especially if the tumor is more infiltrating is to cut the
tumor in half to definitively establish depth of invasion and
then remove it in two pieces. For larger tumors, en bloc
resection is either challenging or impossible. For larger
tumors, the tumor is removed in sections starting at one end
Fig. 2 Image showing the eye protection used in patients undergoing
laser procedures
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completely resect the tumor. This technique initially came
under significant criticism because it violated classic
Halstedian principles of en bloc resection. Extensive study
by Steiner [39, 57] and others [45, 58–60] has demonstrated
that there is no sacrifice of oncologic control using a block-
wise resection of the tumor in discrete segments.
An advantage of removing the tumor in sections is the
ability to precisely define the depth of tumor invasion. A
significant risk of en bloc resections is the inability to
determine the depth of tumor penetration, and there is a risk
of unknowingly resecting too close to the tumor margin at
the deepest and least accessible portion of the tumor. By
cutting directly through the tumor under high magnifica-
tion, the depth of tumor penetration can be seen and
appropriate deep margins delineated.
Once the larynx is exposed and the tumor and surrounding
structures are visualized, the surgeon marks the peripheral
margins using the CO2 laser. The size of the margin depends
on the location and stage of the tumor and if the patient is
undergoing primary treatment or resection of recurrent
disease. If there has been prior RT, wider margins are taken
because of the higher risk of an infiltrative pattern of spread
through the tissues. For small glottic tumors, a margin of as
little as 1 mm is necessary. For deep margins, several
millimeters, and ideally a connective tissue barrier are
chosen for margins of resection.
Successful resection of tumors requires the laser to
perform a variety of tasks from tissue ablation, precise
cutting, and coagulation of tissues. These tasks require
different techniques and differing laser energies, spot sizes,
and pulse modes. It is important to emphasize that for a
given application, there are no fixed settings, and that
practice patterns vary significantly by physician. Several
laser parameters are selected for each particular case,
including: (a) power, (b) spot size, (c) exposure time, and
(d) power (pulse) delivery. Laser energy can be delivered
through intermittent pulses, repeated pulses, continuous
wave (CW), or use of very rapid (millisecond) pulse
delivery in the form of ultrapulse or superpulse mode.
CW mode produces surrounding tissue damage from
thermal spread of the laser energy. In order to produce
adequate cutting and hemostasis with limited char forma-
tion and thermal spread, alternative pulse delivery modes
have been developed to allow tissue cutting and hemostasis
while limiting thermal damage to surrounding tissues. By
producing high-energy, short-duration pulses in rapid
succession, tissue ablation can occur with limited heat
damage to surrounding tissues. The two most common
modes, ultrapulse and superpulse, utilize slightly different
strategies to produce rapidly pulsed waves that incorporate
high peak power delivered in millisecond pulses. Super-
pulse mode delivers short bursts (less than 1 ms) in rapid
succession. The energy profile of the beam is characterized
by a high initial peak energy spike with rapid drop in
energy over duration of the pulse. The ultrapulse mode
delivers a short pulse with a rapid peak onset, relatively
constant energy delivery for the duration of the pulse, and
Fig. 4 Selection of various laryngoscopes used in TLM for tumor
exposure
Fig. 3 Specialized laser-resistant
protected endotracheal tube
covered with an aluminum wrap
118 Lasers Med Sci (2011) 26:113–124rapid decline in power at the end of the pulse, approximat-
ing a square wave. The superpulse mode has higher peak
energy but less total energy delivery per pulse and more
rapid pulse delivery, while ultrapulse mode has lower peak
energy in each pulse, higher energy delivered with each
pulse, and longer duration between pulses [61, 62]. From a
practical standpoint, the clinical differences between the
two pulse modes is subtle, although the thermal damage
from the superpulse mode is reported to be slightly greater
than with utrapulse mode than the superpulse mode [62].
There is no “cookbook” formula for selecting laser
energy, spot size, or pulse duration, but basic principles for
different operative tasks can be summarized as follows:
& When cutting through gross tumor it is necessary to
increase the power as high as 20 W and with a beam
diameter as low as 400 μm, using a continuous wave
pulse to rapidly penetrate the tumor and have adequate
hemostasis.
& Utilize traction and counter traction to place tissues on
tension. As the laser cuts through the tissues, they
separate; exposing underlying structures and this also
produces decreased char formation.
& When dissecting near large vessels or nerves, it is
important to decrease power, defocus the beam to
increase spot size, and utilize conventional dissection
techniques to expose vessels and nerves.
Fig. 7 Surgical microscope (double arrow) used in TLM, coupled
with a micromanipulator (single arrow)
Fig. 6 Patient under suspension laryngoscopy, using a laryngoscope
(arrow) and a suspension arm (double arrow)
Fig. 5 a Insertion of laryngeal
endoscope through the oral
cavity to visualize the laryngeal
structures. b Classical view
through the laryngoscope, where
the vocal cords are seen
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mately 1 mm), improved hemostasis is achieved using a
defocused beam with increased power.
& Large vessels will not be handled adequately with the
laser. Liberal use of hemostatic clips, bipolar cautery, or
monopolar cautery is recommended for medium- to
larger-sized vessels.
& Ultrapulse and superpulse modes are generally used to
define margins, cut through normal tissues, and to
perform precise tissue dissection. They produce less
surrounding damage and char formation, which results
in better anatomic visualization. Decreasing the peak
pulse energy results in decreased penetration with each
pulse and is useful for fine dissections.
○ Ultrapulse and superpulse modes are also helpful for
cutting through bone or cartilage when used with
high power settings.
As the tumor is removed in sections, the specimens are
carefully labeled and oriented for the pathologist. Often,
marking ink used by the pathologist is placed on the true
margins in the operating room by the surgeon. It is critical
to have precise communication and collaboration with the
pathologist to correctly interpret margin status for these
complex specimens. In complicated cases, the specimen is
often delivered to the pathologist managing the case by the
surgeon to ensure correct orientation of the specimen.
Frozen-section margins are sent based on the surgeon’s
judgment of areas at greatest risk for recurrence. If positive
margins are reported by the pathologist, additional tissue is
removed until the margins are clear (Fig. 9). Following
resection, hemostasis is ensured, and the wound is left open
without reconstruction to heal by secondary intention
(Fig. 10).
Postoperative care and feeding
The postoperative care regimen of the patient is tailored to
the extent of the resection. The two most critical concerns
are postoperative bleeding into the airway, and airway
obstruction from edema. Thus, for larger resections or those
involving the supraglottis, the patient is initially managed in
the ICU. After 48 h, the risk of major bleeding is
significantly decreased, although there can be delayed
hemorrhage from sloughing of eschar after 7–10 days. If
there is significant bleeding, securing the airway through
intubation, or if necessary, tracheostomy is of primary
concern to prevent drowning from aspirated blood.
Once the patient is awake and stable, oral alimentation
with ice chips and water is started. This clears secretions
and inflammatory materials, and helps keep the wound bed
clean. Diet is advanced as tolerated. Decisions regarding
oral alimentation rest on the extent of the resection, and
patient factors. If the patient is expected to have compro-
Fig. 8 Specially designed
microlaryngeal instrumentation
for the use in TLM. a Forceps
and scissors. b Insulated
cannula for suction and
unipolar coagulation
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function, mental status, or prior radiotherapy, a nasogastric
feeding tube is placed and swallowing evaluations are
obtained. Antibiotics to cover oral flora are given for 24 h,
and surgical practices vary, with some practitioners stop-
ping at 24 h, and others providing more extended coverage
after discharge because of the large open wound in a
contaminated field.
The final pathologic findings and margin status are
reviewed carefully to ensure complete tumor eradication. If
there are positive or close margins, the location is
determined based on review of the specimens with
anatomic maps of the resection. A second procedure to
remove focal areas where there are close or positive
margins is performed. Depending on the oncological stage,
the likelihood of need for a second resection ranges from as
low as 5% in early glottic carcinoma to up to 29% in
advance tumors, to definitively clear close or positive
margins [57, 63–65].
Complications
In general, TLM is well tolerated with low complication
rates, and generally improved functional outcome compared
to corresponding open procedures resecting the same size
tumor. Early postoperative hemorrhage (described above) is
a potentially lethal complication. Often there will be a small
amount of bleeding, but significant bleeding from a major
artery in the larynx can result in aspiration of blood into the
airway. It is critical in this situation to secure the airway,
either by endotracheal intubation or by performing a
tracheostomy, followed by operative control of hemorrhage.
Airway obstruction is uncommon, as resection of the tumor
generally provides an airway that is more widely patent
following surgery. Since the neck is not incised, there is
much less postoperative swelling and edema that character-
izes open surgical procedures on the larynx. However,
prolonged tongue retraction and compression during long
operations can result in soft tissue ischemia, and in tongue
edema postoperatively. Additionally, prolonged displace-
ment of the tongue by the laryngoscope can cause
temporary lingual or hypoglossal paresis. In cases lasting
more than 1–2 h, periodically releasing suspension to allow
blood flow to the tongue markedly decreases the likelihood
of developing postoperative tongue swelling or nerve
dysfunction. The neuropathy caused by retraction is
temporary, and generally resolves over several weeks. Also
mentioned under postoperative care, aspiration can be
Fig. 9 Schematic depiction
of how the tumor of the larynx
is removed. It is removed by
cutting through the tumor and
removing it in sections
Fig. 10 a Image showing a patient with the diagnosis of glottic squamous cell carcinoma. b Immediate post-op, after removal of the tumor. c Results
6 months after the surgery was performed
Lasers Med Sci (2011) 26:113–124 121caused by extensive resection, preexisting laryngeal im-
pairment, advanced age or poor health. Preoperative and
postoperative assessment to determine the risk for aspira-
tion is necessary to prevent development of aspiration
pneumonia. Other complications encountered include:
mucosal burns of the lips, oral cavity or oropharynx, dental
injuries (loosened or chipped teeth), infection, dysphagia,
and airway fires or burns [66–71].
Summary
TLM is an emerging technique for the treatment of
laryngeal cancer and other head and neck cancers.
Although several lasers may be used, most consider the
CO2 laser the most versatile laser for the great majority of
applications. Technological advances in microscope de-
sign, lasers, surgical instruments, energy beam profile, and
delivery systems have made resection of tumors through
the endoscope possible. Demonstration that tissues could
be resected in a logical stepwise progression to systemat-
ically clear the field of tumor with oncologic margins
eliminated the need to attempt “en bloc” removal. This
expanded the extent of resections that can be safely
performed. With new technology and new surgical
techniques, incorporation of TLM into the surgical
armamentarium requires commitment to learn the techni-
cally challenging procedures, and institutional commit-
ment of resources to purchase necessary equipment to
perform these procedures. Careful study of outcomes by
Steiner and others [24, 38–41, 57] have demonstrated
improved functional outcome with at least equal oncologic
outcome. This has resulted in gradual but progressive
expansion of the techniques globally.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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